Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Reynolds

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Pediatric Clinics of North America|May 24, 2011
Sleep and autism spectrum disordersAnn M Reynolds, Beth A Malow
Respirology (Carlton, Vic.)|March 19, 2002
Interleukin-1beta and tumour necrosis factor-alpha increase microvascular leakage in the guinea pig tracheaAnn M Reynolds, Mark D Holmes, Raffaele Scicchitano
Respirology (Carlton, Vic.)|January 27, 2016
BMPR2 gene therapy for PAH acts via Smad and non-Smad signallingRebecca L Harper, Ann M Reynolds, Claudine S Bonder, et al.
Pediatrics|November 3, 2012
Complementary and alternative medicine use in a large pediatric autism sampleJames M Perrin, Daniel L Coury, Susan L Hyman, et al.
Journal of Autism and Developmental Disorders|March 4, 2018
Modification of the Children's Sleep Habits Questionnaire for Children with Autism Spectrum DisorderTerry Katz, Amy M Shui, Cynthia R Johnson, et al.
Lung Cancer (Amsterdam, Netherlands)|July 25, 2006
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2Katherine M Finan, Greg Hodge, Ann M Reynolds, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2016
Corrigendum to "In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2" [Lung Cancer 53 (3) (September 2006) 273-284]Katherine M Finan, Greg Hodge, Ann M Reynolds, et al.
Pediatrics|February 25, 2016
Sleep Difficulties and Medications in Children With Autism Spectrum Disorders: A Registry StudyBeth A Malow, Terry Katz, Ann M Reynolds, et al.
Pharmacogenomics|March 4, 2021
Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patientsIna Liko, Yee Ming Lee, Danielle L Stutzman, et al.
Pediatrics|February 13, 2019
Sleep Problems in 2- to 5-Year-Olds With Autism Spectrum Disorder and Other Developmental DelaysAnn M Reynolds, Gnakub N Soke, Katherine R Sabourin, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Pediatric Clinics of North America|May 24, 2011
Sleep and autism spectrum disordersAnn M Reynolds, Beth A Malow
Respirology (Carlton, Vic.)|March 19, 2002
Interleukin-1beta and tumour necrosis factor-alpha increase microvascular leakage in the guinea pig tracheaAnn M Reynolds, Mark D Holmes, Raffaele Scicchitano
Respirology (Carlton, Vic.)|January 27, 2016
BMPR2 gene therapy for PAH acts via Smad and non-Smad signallingRebecca L Harper, Ann M Reynolds, Claudine S Bonder, et al.
Pediatrics|November 3, 2012
Complementary and alternative medicine use in a large pediatric autism sampleJames M Perrin, Daniel L Coury, Susan L Hyman, et al.
Journal of Autism and Developmental Disorders|March 4, 2018
Modification of the Children's Sleep Habits Questionnaire for Children with Autism Spectrum DisorderTerry Katz, Amy M Shui, Cynthia R Johnson, et al.
Lung Cancer (Amsterdam, Netherlands)|July 25, 2006
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2Katherine M Finan, Greg Hodge, Ann M Reynolds, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2016
Corrigendum to "In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2" [Lung Cancer 53 (3) (September 2006) 273-284]Katherine M Finan, Greg Hodge, Ann M Reynolds, et al.
Pediatrics|February 25, 2016
Sleep Difficulties and Medications in Children With Autism Spectrum Disorders: A Registry StudyBeth A Malow, Terry Katz, Ann M Reynolds, et al.
Pharmacogenomics|March 4, 2021
Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patientsIna Liko, Yee Ming Lee, Danielle L Stutzman, et al.
Pediatrics|February 13, 2019
Sleep Problems in 2- to 5-Year-Olds With Autism Spectrum Disorder and Other Developmental DelaysAnn M Reynolds, Gnakub N Soke, Katherine R Sabourin, et al.
Pageof 3